Question · Q4 2025
Daniel Harriman asked for an update on Balchem's international sales success, particularly within specialty products. He also questioned the early impacts on pricing dynamics and competitive conditions in the Animal Nutrition & Health (ANH) segment in Europe following December's anti-dumping announcement.
Answer
Chairman, President, and CEO Ted Harris confirmed that half of recent growth came from international markets, driven by strategic geographic expansion, especially in Human Nutrition & Health across Asia, South America, and Europe. He noted faster international growth compared to domestic, with ANH ruminant and specialty products also contributing. CFO Martin Bengtsson confirmed clear improvements in ANH Europe, with increased volumes and firming prices in Q1/Q2, though still early. He highlighted a significant win in defining choline's country of origin, making circumvention of dumping duties harder.
Ask follow-up questions
Fintool can predict
BCPC's earnings beat/miss a week before the call


